Brazil
· Delayed Price · Currency is BRL BVMF: PNVL3 Statistics
Total Valuation
Dimed S.A. Distribuidora de Medicamentos has a market cap or net worth of BRL 1.32 billion. The enterprise value is 2.26 billion.
| Market Cap | 1.32B |
| Enterprise Value | 2.26B |
Important Dates
The next estimated earnings date is Monday, March 24, 2025.
| Earnings Date | Mar 24, 2025 |
| Ex-Dividend Date | Dec 17, 2024 |
Share Statistics
Dimed S.A. Distribuidora de Medicamentos has 149.36 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 149.36M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | -12.63% |
| Owned by Insiders (%) | 46.35% |
| Owned by Institutions (%) | 16.43% |
| Float | 80.13M |
Valuation Ratios
The trailing PE ratio is 12.83 and the forward PE ratio is 8.18. Dimed S.A. Distribuidora de Medicamentos's PEG ratio is 0.55.
| PE Ratio | 12.83 |
| Forward PE | 8.18 |
| PS Ratio | 0.27 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.20 |
| P/FCF Ratio | 8.39 |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.94, with an EV/FCF ratio of 14.37.
| EV / Earnings | 21.87 |
| EV / Sales | 0.47 |
| EV / EBITDA | 8.94 |
| EV / EBIT | 12.61 |
| EV / FCF | 14.37 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.96.
| Current Ratio | 1.60 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 4.52 |
| Debt / FCF | 7.26 |
| Interest Coverage | 1.74 |
Financial Efficiency
Return on equity (ROE) is 8.87% and return on invested capital (ROIC) is 4.93%.
| Return on Equity (ROE) | 8.87% |
| Return on Assets (ROA) | 3.63% |
| Return on Capital (ROIC) | 4.93% |
| Revenue Per Employee | 474,891 |
| Profits Per Employee | 10,207 |
| Employee Count | 10,284 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 3.15 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.62% in the last 52 weeks. The beta is 0.40, so Dimed S.A. Distribuidora de Medicamentos's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -26.62% |
| 50-Day Moving Average | 9.63 |
| 200-Day Moving Average | 10.20 |
| Relative Strength Index (RSI) | 36.81 |
| Average Volume (20 Days) | 445,054 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dimed S.A. Distribuidora de Medicamentos had revenue of BRL 4.82 billion and earned 103.55 million in profits. Earnings per share was 0.69.
| Revenue | 4.82B |
| Gross Profit | 1.53B |
| Operating Income | 179.60M |
| Pretax Income | 103.73M |
| Net Income | 103.55M |
| EBITDA | 123.65M |
| EBIT | 179.60M |
| Earnings Per Share (EPS) | 0.69 |
Balance Sheet
The company has 200.87 million in cash and 1.14 billion in debt, giving a net cash position of -942.98 million or -6.31 per share.
| Cash & Cash Equivalents | 200.87M |
| Total Debt | 1.14B |
| Net Cash | -942.98M |
| Net Cash Per Share | -6.31 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 8.00 |
| Working Capital | 717.51M |
Cash Flow
In the last 12 months, operating cash flow was 274.49 million and capital expenditures -116.94 million, giving a free cash flow of 157.55 million.
| Operating Cash Flow | 274.49M |
| Capital Expenditures | -116.94M |
| Free Cash Flow | 157.55M |
| FCF Per Share | 1.05 |
Margins
Gross margin is 31.75%, with operating and profit margins of 3.73% and 2.15%.
| Gross Margin | 31.75% |
| Operating Margin | 3.73% |
| Pretax Margin | 2.15% |
| Profit Margin | 2.15% |
| EBITDA Margin | 2.57% |
| EBIT Margin | 3.73% |
| FCF Margin | 3.27% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 2.84%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 2.84% |
| Dividend Growth (YoY) | 37.69% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 31.75% |
| Buyback Yield | -0.73% |
| Shareholder Yield | 2.12% |
| Earnings Yield | 7.79% |
| FCF Yield | 11.92% |
Stock Splits
The last stock split was on March 23, 2020. It was a forward split with a ratio of 30.
| Last Split Date | Mar 23, 2020 |
| Split Type | Forward |
| Split Ratio | 30 |
Scores
Dimed S.A. Distribuidora de Medicamentos has an Altman Z-Score of 2.53. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.53 |
| Piotroski F-Score | n/a |